Literature DB >> 23864674

Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia.

Rahul Bharadwaj1, Yan Jiang, Wenjie Mao, Mira Jakovcevski, Aslihan Dincer, Winfried Krueger, Krassimira Garbett, Catheryne Whittle, Jogender Singh Tushir, Jia Liu, Adolfo Sequeira, Marquis P Vawter, Paul D Gardner, Patrizia Casaccia, Theodore Rasmussen, William E Bunney, Karoly Mirnics, Kensuke Futai, Schahram Akbarian.   

Abstract

Little is known about chromosomal loopings involving proximal promoter and distal enhancer elements regulating GABAergic gene expression, including changes in schizophrenia and other psychiatric conditions linked to altered inhibition. Here, we map in human chromosome 2q31 the 3D configuration of 200 kb of linear sequence encompassing the GAD1 GABA synthesis enzyme gene locus, and we describe a loop formation involving the GAD1 transcription start site and intergenic noncoding DNA elements facilitating reporter gene expression. The GAD1-TSS(-50kbLoop) was enriched with nucleosomes epigenetically decorated with the transcriptional mark, histone H3 trimethylated at lysine 4, and was weak or absent in skin fibroblasts and pluripotent stem cells compared with neuronal cultures differentiated from them. In the prefrontal cortex of subjects with schizophrenia, GAD1-TSS(-50kbLoop) was decreased compared with controls, in conjunction with downregulated GAD1 expression. We generated transgenic mice expressing Gad2 promoter-driven green fluorescent protein-conjugated histone H2B and confirmed that Gad1-TSS(-55kbLoop), the murine homolog to GAD1-TSS(-50kbLoop), is a chromosomal conformation specific for GABAergic neurons. In primary neuronal culture, Gad1-TSS(-55kbLoop) and Gad1 expression became upregulated when neuronal activity was increased. We conclude that 3D genome architectures, including chromosomal loopings for promoter-enhancer interactions involved in the regulation of GABAergic gene expression, are conserved between the rodent and primate brain, and subject to developmental and activity-dependent regulation, and disordered in some cases with schizophrenia. More broadly, the findings presented here draw a connection between noncoding DNA, spatial genome architecture, and neuronal plasticity in development and disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23864674      PMCID: PMC3713726          DOI: 10.1523/JNEUROSCI.1252-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  84 in total

Review 1.  Neuronal dynamics and neuropsychiatric disorders: toward a translational paradigm for dysfunctional large-scale networks.

Authors:  Peter J Uhlhaas; Wolf Singer
Journal:  Neuron       Date:  2012-09-20       Impact factor: 17.173

2.  A new paradigm for understanding gamma-aminobutyric acid cell pathology in schizophrenia?

Authors:  Francine M Benes
Journal:  Biol Psychiatry       Date:  2012-11-01       Impact factor: 13.382

3.  Specific trans-synaptic interaction with inhibitory interneuronal neurexin underlies differential ability of neuroligins to induce functional inhibitory synapses.

Authors:  Kensuke Futai; Christopher D Doty; Brian Baek; Jubin Ryu; Morgan Sheng
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

4.  Genome-wide chromatin state transitions associated with developmental and environmental cues.

Authors:  Jiang Zhu; Mazhar Adli; James Y Zou; Griet Verstappen; Michael Coyne; Xiaolan Zhang; Timothy Durham; Mohammad Miri; Vikram Deshpande; Philip L De Jager; David A Bennett; Joseph A Houmard; Deborah M Muoio; Tamer T Onder; Ray Camahort; Chad A Cowan; Alexander Meissner; Charles B Epstein; Noam Shoresh; Bradley E Bernstein
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

5.  Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia.

Authors:  David W Volk; Takurou Matsubara; Siyu Li; Elizabeth J Sengupta; Danko Georgiev; Yoshio Minabe; Allan Sampson; Takanori Hashimoto; David A Lewis
Journal:  Am J Psychiatry       Date:  2012-10       Impact factor: 18.112

6.  Genome-wide profiling of multiple histone methylations in olfactory cells: further implications for cellular susceptibility to oxidative stress in schizophrenia.

Authors:  S Kano; C Colantuoni; F Han; Z Zhou; Q Yuan; A Wilson; Y Takayanagi; Y Lee; J Rapoport; W Eaton; N Cascella; H Ji; D Goldman; A Sawa
Journal:  Mol Psychiatry       Date:  2012-08-28       Impact factor: 15.992

Review 7.  The dynamics of DNA methylation in schizophrenia and related psychiatric disorders.

Authors:  Dennis R Grayson; Alessandro Guidotti
Journal:  Neuropsychopharmacology       Date:  2012-09-05       Impact factor: 7.853

8.  Modeling interneuron dysfunction in schizophrenia.

Authors:  Martin J Schmidt; Karoly Mirnics
Journal:  Dev Neurosci       Date:  2012-05-08       Impact factor: 2.984

9.  Human-specific histone methylation signatures at transcription start sites in prefrontal neurons.

Authors:  Hennady P Shulha; Jessica L Crisci; Denis Reshetov; Jogender S Tushir; Iris Cheung; Rahul Bharadwaj; Hsin-Jung Chou; Isaac B Houston; Cyril J Peter; Amanda C Mitchell; Wei-Dong Yao; Richard H Myers; Jiang-Fan Chen; Todd M Preuss; Evgeny I Rogaev; Jeffrey D Jensen; Zhiping Weng; Schahram Akbarian
Journal:  PLoS Biol       Date:  2012-11-20       Impact factor: 8.029

10.  A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression.

Authors:  Jerry Guintivano; Martin J Aryee; Zachary A Kaminsky
Journal:  Epigenetics       Date:  2013-02-20       Impact factor: 4.528

View more
  28 in total

Review 1.  Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia.

Authors:  David A Lewis
Journal:  Curr Opin Neurobiol       Date:  2013-11-30       Impact factor: 6.627

Review 2.  Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia.

Authors:  Hirofumi Morishita; Marija Kundakovic; Lucy Bicks; Amanda Mitchell; Schahram Akbarian
Journal:  Neurobiol Learn Mem       Date:  2015-04-04       Impact factor: 2.877

Review 3.  Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia.

Authors:  Amanda C Mitchell; Yan Jiang; Cyril Peter; Schahram Akbarian
Journal:  Schizophr Res       Date:  2014-10-31       Impact factor: 4.939

4.  Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.

Authors:  Sohei Kimoto; Mark M Zaki; H Holly Bazmi; David A Lewis
Journal:  JAMA Psychiatry       Date:  2015-08       Impact factor: 21.596

Review 5.  Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.

Authors:  Emily L Ricq; Jacob M Hooker; Stephen J Haggarty
Journal:  Psychiatry Clin Neurosci       Date:  2016-09-07       Impact factor: 5.188

Review 6.  The epigenomics of schizophrenia, in the mouse.

Authors:  Behnam Javidfar; Royce Park; Bibi S Kassim; Lucy K Bicks; Schahram Akbarian
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07-12       Impact factor: 3.568

Review 7.  Spatial genome organization and cognition.

Authors:  Prashanth Rajarajan; Sergio Espeso Gil; Kristen J Brennand; Schahram Akbarian
Journal:  Nat Rev Neurosci       Date:  2016-10-06       Impact factor: 34.870

8.  Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder.

Authors:  W Brad Ruzicka; Sivan Subburaju; Francine M Benes
Journal:  JAMA Psychiatry       Date:  2015-06       Impact factor: 21.596

9.  Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia.

Authors:  Jill R Glausier; Sohei Kimoto; Kenneth N Fish; David A Lewis
Journal:  Biol Psychiatry       Date:  2014-05-29       Impact factor: 13.382

10.  Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia.

Authors:  Brad R Rocco; David A Lewis; Kenneth N Fish
Journal:  Biol Psychiatry       Date:  2015-08-07       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.